rs3775291 — TLR3 Leu412Phe

TLR3 Leu412Phe — When the Antiviral Alarm Is Half as Loud

Toll-like receptor 3 (TLR3)¹¹ Toll-like receptor 3 (TLR3)
TLR3 is the innate immune system's dedicated sensor for double-stranded RNA (dsRNA) — the molecular signature produced when RNA viruses replicate inside cells stands guard in endosomes and on cell surfaces, scanning for viral invaders. When TLR3 detects dsRNA, it triggers production of type I interferons (IFN-α/β)²² type I interferons (IFN-α/β)
Interferons are signaling proteins that put neighboring cells into an antiviral state, slowing viral spread and activating natural killer cells and cytotoxic T lymphocytes — the body's fastest antiviral alarm. The rs3775291 variant (c.1234C>T), which swaps leucine for phenylalanine at amino acid 412, turns that alarm down significantly. Carriers produce a structurally altered receptor that binds viral dsRNA at roughly half the affinity of the normal form.

This variant is remarkably common in Europeans — the T allele appears in about 34% of European blood donors, with roughly 13% of Europeans carrying two copies (TT). By contrast, the T allele is far rarer in African and East Asian populations (approximately 5% and 10% respectively), a pattern that likely reflects ancient differences in viral exposure history during human migration and settlement.

The Mechanism

The leucine-to-phenylalanine substitution occurs in TLR3's ectodomain³³ ectodomain
The extracellular portion of TLR3 that directly contacts dsRNA ligands, forming the binding interface — specifically in a loop region that contacts the dsRNA phosphate backbone. A landmark functional study found that the L412F mutation reduces TLR3's dsRNA-binding capacity to just 51% of wild-type levels⁴⁴ landmark functional study found that the L412F mutation reduces TLR3's dsRNA-binding capacity to just 51% of wild-type levels
Measured using cell-based binding assays with poly(I:C), a synthetic dsRNA mimic; protein expression and surface distribution were unaffected. Critically, the protein is made in normal amounts and traffics correctly — the defect is purely in binding affinity, not receptor availability.

Downstream consequences include reduced NF-κB activation⁵⁵ NF-κB activation
NF-κB is a master transcription factor that drives expression of hundreds of immune genes including cytokines, adhesion molecules, and antiviral effectors, reduced IFN-β production, and — as more recent work has revealed — impaired macroautophagy⁶⁶ macroautophagy
The cellular process of engulfing and digesting damaged organelles and intracellular pathogens; critical for clearing virally infected material. This autophagy impairment appears particularly important in severe viral infections, potentially slowing the cell's ability to dispose of viral particles.

The Evidence

The clinical consequences of half-normal TLR3 function play out differently across diseases, sometimes strikingly in opposite directions.

Viral infections — increased susceptibility: A meta-analysis of 18 case-control studies (3,118 cases and 4,368 controls) found the T allele associated with a 16% increase in overall infectious disease risk⁷⁷ meta-analysis of 18 case-control studies (3,118 cases and 4,368 controls) found the T allele associated with a 16% increase in overall infectious disease risk
Dominant model OR=1.16, 95% CI 1.04–1.28, p=0.004; diseases included hepatitis B/C, HIV, dengue, tick-borne encephalitis, herpes simplex virus, and Japanese encephalitis. However, results were geographically heterogeneous: in European studies the T allele was actually protective (OR=0.83), while Asian and American studies showed increased risk (OR=1.37 and 1.42 respectively). This likely reflects differences in which pathogens dominate in each region and how TLR3 interacts with other immune loci.

For herpes simplex encephalitis (HSE), rare but serious TLR3 pathway mutations explain approximately 5% of childhood HSE cases⁸⁸ rare but serious TLR3 pathway mutations explain approximately 5% of childhood HSE cases
Among 120 HSE patients studied, 6 (5%) had TLR3 mutations; affected children had 66% HSE recurrence vs 10% in the broader cohort. While rs3775291 is a common hypomorphic variant rather than a complete loss-of-function mutation, it exemplifies the principle that TLR3 pathway competence is non-redundant in the brain during primary HSV infection in children. Separate case studies have documented HSE in adults heterozygous for TLR3 mutations.

For HIV, the T allele appears protective in highly exposed Europeans — 80% of highly exposed HIV-seronegative intravenous drug users carried at least one T allele versus 55% in blood donor controls⁹⁹ 80% of highly exposed HIV-seronegative intravenous drug users carried at least one T allele versus 55% in blood donor controls
Study of 497 blood donors and highly exposed seronegative cohort; OR=0.25 for HIV seropositivity among T allele carriers, 95% CI 0.07–0.87. This paradox (less TLR3 function = better HIV resistance) may relate to HIV's ability to exploit TLR3 signaling for its own replication, making a less responsive receptor protective in this particular context.

Age-related macular degeneration — protective: Perhaps the most consistent finding is that the TT genotype protects against geographic atrophy (advanced dry AMD)¹⁰¹⁰ protects against geographic atrophy (advanced dry AMD)
Meta-analysis of 9 studies with 7,400 AMD cases and 13,579 controls; protective OR=0.88 in recessive model, specifically in Caucasians. The biological rationale is compelling: in the aging retina, TLR3 on retinal pigment epithelial cells responds to debris from dying photoreceptors, triggering inflammatory damage. Reduced TLR3 activation attenuates this harmful cycle, protecting vision. This is a case where weaker receptor function is genuinely beneficial.

Pulmonary sarcoidosis: Two independent Caucasian cohorts (Irish and American) found TLR3 L412F significantly associated with persistent clinical disease¹¹¹¹ Two independent Caucasian cohorts (Irish and American) found TLR3 L412F significantly associated with persistent clinical disease
Irish cohort: n=228 patients, 263 controls; American replication cohort: n=123 patients; fibroblasts from 412F-homozygous patients showed reduced IFN-β and dysregulated fibroproliferative responses. Impaired viral clearance may trigger granuloma formation that fails to resolve, locking the disease into a chronic state.

COVID-19: The L412F polymorphism emerged as a marker of COVID-19 severity, particularly in males¹²¹² a marker of COVID-19 severity, particularly in males
Association strengthened in male sub-cohorts; mechanistic link via impaired autophagy, which slows clearance of viral material. Among COVID-19 patients treated with hydroxychloroquine (which further impairs autophagy), L412F carriers showed significantly reduced 28-day survival (p=0.038), suggesting the autophagy pathway is specifically important in this context.

Practical Implications

The duality of this variant — harmful for some viral infections, protective for macular degeneration — means the practical guidance depends heavily on context. TT homozygotes have the strongest protection against AMD but the most reduced antiviral dsRNA sensing. CT heterozygotes sit in between: partially reduced TLR3 function with correspondingly intermediate risks and benefits.

For viral defense, the most actionable insight is vigilance around prevention — ensuring vaccinations are current, minimizing high-risk exposures, and seeking early medical care for neurological symptoms after herpes virus infections. For long-term eye health, TT carriers have a genuine genetic advantage that does not require any active management.

Interactions

TLR3 works within a broader innate immune network. TLR9 (rs352140) senses CpG-rich bacterial and viral DNA¹³¹³ TLR9 (rs352140) senses CpG-rich bacterial and viral DNA
TLR3 senses viral dsRNA; TLR9 senses microbial DNA — together they cover complementary pathogen signatures, while TLR4 (rs4986790) responds to bacterial endotoxin (LPS)¹⁴¹⁴ TLR4 (rs4986790) responds to bacterial endotoxin (LPS)
These three TLRs collectively provide pattern recognition for the major classes of microbial threats. Carriers of multiple hypomorphic TLR variants may have compoundly reduced innate immune surveillance, particularly relevant for individuals with TLR3 L412F combined with TLR4 Asp299Gly — both reduce first-line pattern recognition.

The rs5743305 variant (promoter region, −926bp) reduces TLR3 transcription and has been co-studied with rs3775291 — carriers of both variants showed the lowest anti-viral antibody responses in measles vaccine studies. rs3775290 (exon 4, Phe459Phe) is a silent SNP often studied alongside rs3775291 in haplotype analyses of TLR3.